Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Climb Bio, Inc. (CLYM) had Return on Equity of -10.75% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-20.78M |
|
-- |
|
-- |
|
$23.02M |
|
$-23.02M |
|
$2.24M |
|
$-20.78M |
|
$-20.78M |
|
$-20.78M |
|
$-20.78M |
|
$-20.78M |
|
$-20.78M |
|
$-23.02M |
|
$-23.69M |
|
67.46M |
|
67.46M |
|
$-0.31 |
|
$-0.31 |
|
| Balance Sheet Financials | |
$100.28M |
|
-- |
|
$100.46M |
|
$200.74M |
|
$7.04M |
|
-- |
|
$0.32M |
|
$7.36M |
|
$193.38M |
|
$193.38M |
|
$193.38M |
|
67.58M |
|
| Cash Flow Statement Financials | |
$-15.43M |
|
$-42.75M |
|
-- |
|
$87.23M |
|
$29.02M |
|
$-58.21M |
|
$2.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.25 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-15.43M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-10.75% |
-10.75% |
|
-10.35% |
|
-10.75% |
|
$2.86 |
|
$-0.23 |
|
$-0.23 |
|